Patents by Inventor Julia Hilliard

Julia Hilliard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200155492
    Abstract: Embodiments of the present invention relate generally the use of compositions comprising a glutathione precursor and a selenium source, e.g., compositions which elevate intracellular glutathione, in the prevention and treatment of Zika viral diseases, e.g., Zika fever. Related embodiments are directed to use of such compositions, e.g., compositions comprising a glutathione precursor and a selenium source, in reducing the infectivity of Zika viruses or Zika viral particles.
    Type: Application
    Filed: May 1, 2018
    Publication date: May 21, 2020
    Inventors: Albert CRUM, Julia HILLIARD
  • Publication number: 20190284259
    Abstract: Embodiments of the disclosure relate generally to B virus epitopes, and more specifically to B virus epitopes and monoclonal antibodies (MABs) that can distinguish between different B viruses specific to different hosts and can further neutralize said viruses; compositions containing the epitopes and MABs and nucleic acids encoding the epitopes and MABs; and specific B virus peptides and MABs that can be used in diagnostic assays or as sources for vaccines or other therapeutic interventions.
    Type: Application
    Filed: July 20, 2017
    Publication date: September 19, 2019
    Inventors: David Katz, Julia Hilliard
  • Publication number: 20120270292
    Abstract: The present disclosure relates generally to systems and methods for the photo-inactivation of microorganisms. More specifically, the present invention is directed towards the photo-inactivation of microorganisms, such as viruses, using at least one furanocoumarin and broad spectrum pulsed light. For example, an aspect of the present invention includes a method for inactivating a herpesvirus, such as herpes B virus or herpes virus papio 2 using a psoralen and broad spectrum pulsed light.
    Type: Application
    Filed: December 20, 2010
    Publication date: October 25, 2012
    Applicant: GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION
    Inventors: Julia Hilliard, David Katz
  • Patent number: 5767265
    Abstract: With the DNA sequence (SEQ ID NO:4:) of monkey B virus which codes for the gB glycoprotein (UL27) (SEQ ID NO:6:) and a portion (UL28) (SEQ ID NO:5:) of an ICP 18.5 kilodalton polypeptide (UL28), methods for early detection of the presence of monkey B virus in humans and monkeys can be performed by amplifying primer sequences and distinguishing the monkey B virus DNA coding for UL27 or UL28 from other herpes virus gB DNA using unique reaction conditions to permit unequivocal differentiation.
    Type: Grant
    Filed: October 10, 1995
    Date of Patent: June 16, 1998
    Assignee: Southwest Foundation for Biomedical Research
    Inventors: Richard Eberle, Darla Black, Franco Scinicariello, Julia Hilliard
  • Patent number: 5487969
    Abstract: With the DNA sequence (SEQ ID NO:4:) of monkey B virus which codes for the gB glycoprotein (UL27) (SEQ ID NO:6:) and a portion (UL28) (SEQ ID NO:5:) of an ICP 18.5 kilodalton polypeptide (UL28), methods for early detection of the presence of monkey B virus in humans and monkeys can be performed by amplifying primer sequences and distinguishing the monkey B virus DNA coding for UL27 or UL28 from other herpes virus gB DNA using unique reaction conditions to permit unequivocal differentiation.
    Type: Grant
    Filed: April 1, 1993
    Date of Patent: January 30, 1996
    Assignee: Southwest Foundation for Biomedical Research
    Inventors: Richard Eberle, Darla Black, Franco Scinicariello, Julia Hilliard